B
Bryce Platt
PharmD · Healthcare Economist
InsightsFrameworksResearchNewsletterSpeakingAbout
ContactSubscribe
Vol. IX · Digital HeadquartersEst. 2021

Understanding the economics behind U.S. healthcare.

Helping healthcare leaders understand the financial incentives shaping pharmacy, Medicare, PBMs, specialty pharmacy, reimbursement, and healthcare policy — through practical frameworks and evidence-based analysis.

Subscribe to the NewsletterExplore Latest Insights
KH
MR
JS
AL
37,000+ healthcare leaders read Bryce weekly
Bryce Platt, PharmD
PORTRAIT · 2025
Bryce Platt, PharmD
DCI
Director
LinkedIn
37,000+
Healthcare leaders following
Streak
1,400+
Days publishing without a break
Role
Director,
Drug Channels Institute
Scroll to explore — Insights, Frameworks, Research
37K+
Healthcare Professionals Following
On LinkedIn, growing daily
1,400+
Consecutive Days Publishing
Daily educational insights
DCI
Director
Drug Channels Institute
12M+
Annual Content Impressions
Across healthcare leadership
Section I · Latest Analysis

Evidence-based perspectives on the forces shaping healthcare today.

View all insights
The Nine Types of Specialty Pharmacies, Explained
Specialty Pharmacy13 min read

The Nine Types of Specialty Pharmacies, Explained

Business models, ownership structures, and channel strategies mapped as one framework — PBM-owned, health-plan-owned, health-system, retail, mail, manufacturer, independent, 340B, and niche.

Read Analysis
Six Hard Pills to Swallow for the Drug Channel
Drug Channels8 min read

Six Hard Pills to Swallow for the Drug Channel

Lower list prices will not guarantee better access. PBMs will not work for free. Plan sponsors will not cover every treatment. The uncomfortable realities behind reform.

Read Analysis
The Employer 340B Playbook
340B10 min read

The Employer 340B Playbook

Five plays employers can run to protect against 340B leakage — fix the PBM contract, control the pharmacy network, optimize the formulary, avoid shared savings, and track the right metrics.

Read Analysis
View All Insights
Editorial Note
“Healthcare decisions are driven by incentives. Everything else is downstream.”
BRYCE PLATT, PHARMD
Section II · Topic Explorer

Browse healthcare by subject, not by date.

A knowledge library organized around the topics that matter most to healthcare leaders, consultants, and policymakers.

01

Drug Channels

How money, product, and incentives move through the supply chain.

42 articlesExplore
02

PBMs

Pharmacy benefit manager economics, contracting, and reform.

38 articlesExplore
03

Specialty Pharmacy

Business models, limited distribution, and site of care.

31 articlesExplore
04

Medicare

Part D redesign, IRA, CMS policy, and beneficiary impact.

27 articlesExplore
05

Drug Pricing

List, net, WAC, and the mechanics behind every dollar.

24 articlesExplore
06

340B

Contract pharmacies, manufacturer restrictions, and drift.

18 articlesExplore
07

Market Access

Coverage decisions, utilization management, and access.

16 articlesExplore
08

Employer Benefits

Plan design, GLP-1 strategy, and cost containment.

14 articlesExplore
09

Healthcare Policy

Legislation, regulation, and operational implications.

22 articlesExplore
Section III · Framework Library

Visual models that simplify complex systems.

Timeless mental models used across executive briefings, industry reports, and conference keynotes.

Framework 01

The Nine Types of Specialty Pharmacies

Separate the business models, ownership structures, and distribution strategies that define modern specialty pharmacy.

SpecialtyBusiness Models
Framework 02

The PBM Incentive Model

Rebates, spread, DIR fees, and vertical integration mapped as one incentive architecture.

PBMsIncentives
Framework 03

The Drug Channel Ecosystem

Manufacturers, wholesalers, pharmacies, PBMs, payers, and beneficiaries — the full circulatory system of pharmacy.

Drug ChannelsSupply Chain
Framework 04

Medicare Part D, Simplified

Deductible, initial coverage, catastrophic, and manufacturer discount phases redrawn for 2025 and beyond.

MedicarePart D
Framework 05

The Employer 340B Playbook

Five plays for self-insured employers to protect against 340B leakage and preserve pharmacy value.

Employer340B
Framework 06

The Healthcare Value Chain

From payer to provider to end-consumer — who assumes risk, who captures margin, and where value leaks.

StrategyValue
View Full Framework Library
Section IV · Research & Publications

Original reports and industry-leading research.

White papers, annual reports, and collaborative research exploring the economics of U.S. healthcare.

Annual ReportVol. XVI
Drug Channels Institute · 2025

The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels Institute2025

An in-depth analysis of the largest pharmacies, PBMs, and their evolving market positions across specialty and mail channels.

Read Report
Industry ReportVol. IX
Drug Channels Institute · 2024

The 2024 Economic Report on U.S. Specialty Pharmacies

Drug Channels Institute2024

Business models, ownership concentration, and the emerging channel dynamics reshaping specialty distribution.

Read Report
White PaperNo. 042
Milliman White Paper · 2022

Employer Pharmacy Benefit Design Under Rising Specialty Cost

Milliman White Paper2022

A structured approach to specialty benefit management for self-insured employers navigating trend pressure.

Read Report
Section V · Speaking

Executive briefings and conference keynotes.

Bryce regularly presents on drug channels, PBM economics, Medicare, specialty pharmacy, and healthcare policy — for boards, health plans, and industry associations.

Speaking engagement
ASEMBIA 2025 · LAS VEGAS
Signature Topics
  • 01The Economics of U.S. Drug Channels
  • 02Inside the PBM: Incentives, Rebates, and Reform
  • 03Medicare Part D in the IRA Era
  • 04Specialty Pharmacy Business Models
  • 05Employer Strategy for GLP-1 Therapies
  • 06The Real Anatomy of a U.S. Drug Price
Formats
KeynotesPanelsPodcastsWebinarsExecutive WorkshopsConference Sessions
Speaking Topics Book Bryce
Bryce Platt

“Explain the incentives, and the market makes sense.”

Section VI · About

Meet Bryce Platt.

Bryce is Director at Drug Channels Institute and one of the leading educators explaining the economics of pharmacy, reimbursement, and healthcare policy. His work helps executives, consultants, providers, researchers, and policymakers understand how incentives shape healthcare markets.

He has published educational content every day for more than four consecutive years, cultivating one of the fastest-growing healthcare audiences on LinkedIn — not through personality, but through clarity.

Read Full Biography
The Drug Channels Brief · Vol. IX

A weekly briefing on the economics of healthcare.

Read by directors, actuaries, journalists, and policymakers. Bryce distills the week’s most consequential pharmacy and drug channel news into one clear framework you can bring to your Monday meeting.

  • One idea per week
    A single framework, unpacked with clarity.
  • 5–10 minute read
    Written for busy executives.
  • Direct to inbox
    No feed algorithms. No noise.
Issue No. 217
July 21, 2025

“Why PBM transparency reform rarely lowers prices.”

  • The incentive map behind the headlines
  • One framework: rebates vs. net cost
  • What to watch next quarter
37,000+ subscribersUnsubscribe anytime
The Drug Channels Brief

Read by 37,000+ healthcare leaders.

No spam. Unsubscribe anytime.

Bryce
Bryce Platt, PharmD
Director, Drug Channels Institute
Topics
  • Drug Channels
  • PBMs
  • Medicare
  • Specialty Pharmacy
  • Drug Pricing
  • 340B
  • Employer Benefits
  • Healthcare Policy
Frameworks
  • Specialty Pharmacies
  • PBM Incentives
  • Drug Channels
  • Part D Simplified
  • Value Chain
Newsletter
  • Subscribe
  • Latest Issue
  • Archive
  • RSS
Speaking
  • Topics
  • Keynotes
  • Podcasts
  • Book Bryce
LinkedIn
  • Follow → 37K+
  • Daily posts
  • Newsletter
Contact
  • General inquiry
  • Media & press
  • Speaking
  • hello@bryceplatt.com
B
© 2026 Bryce Platt, PharmD · All rights reserved.
Vol. IX · Iss. 07·Digital Headquarters·Made with intention.
    The Drug Channels Brief · Vol. IX

    Stay ahead of U.S.
    drug channels.

    One concise briefing. Delivered regularly. Helping healthcare leaders understand pharmacy economics, PBMs, Medicare, reimbursement, specialty pharmacy, and healthcare policy.

    • One idea per week, unpacked with clarity
    • 5–10 minute read, written for busy executives
    • Evidence-based. No spam. Unsubscribe anytime.
    37,000+ readers·Weekly · 5–10 min·Evidence-first